Diagnostic Testing by CFTR Gene Mutation Analysis in a Large Group of Hispanics: Novel Mutations and Assessment of a Population-specific Mutation Spectrum

Overview

Journal J Mol Diagn

Publisher Elsevier

Specialties Molecular Biology
Pathology

Date 2005 Apr 29

PMID 15858154

Citations 18

Authors

Iris Schrijver

Sudha Ramalingam

Ramalingam Sankaran

Steve Swanson

Charles L M Dunlop

Steven Keiles

Richard B Moss

John Oehlert

Phyllis Gardner

E Robert Wassman

Anja Kammesheidt

Affiliations

Soon will be listed here.

Abstract

Characterization of CFTR mutations in the U.S. Hispanic population is vital to early diagnosis, genetic counseling, patient-specific treatment, and the understanding of cystic fibrosis (CF) pathogenesis. The mutation spectrum in Hispanics, however, remains poorly defined. A group of 257 self-identified Hispanics with clinical manifestations consistent with CF were studied by temporal temperature gradient electrophoresis and/or DNA sequencing. A total of 183 mutations were identified, including 14 different amino acid-changing novel variants. A significant proportion (78/85) of the different mutations identified would not have been detected by the ACMG/ACOG-recommended 25-mutation screening panel. Over one third of the mutations (27/85) occurred with a relative frequency >1%, which illustrates that the identified mutations are not all rare. This is supported by a comparison with other large CFTR studies. These results underscore the disparity in mutation identification between Caucasians and Hispanics and show utility for comprehensive diagnostic CFTR mutation analysis in this population.

Citing Articles

Development of a Tagmentation-Based Next-Generation Sequencing Clinical Assay as an Alternative to Capillary Electrophoresis-Based Sequencing.

Kuek W, Chai C, Tham W, Ng A, Lau D, Loo J Mol Genet Genomic Med. 2024; 12(11):e70035.

PMID: 39560203 PMC: 11574739. DOI: 10.1002/mgg3.70035.

Identification of cystic fibrosis transmembrane conductance regulator gene (CFTR) variants: A retrospective study on the western and southern regions of Saudi Arabia.

Almaghamsi T, Attiyah W, Bahasan M, Alotaibi B, AlAhmadi S, Hanbazazh M Saudi Med J. 2023; 44(10):987-994.

PMID: 37777263 PMC: 10541982. DOI: 10.15537/smj.2023.44.10.20230290.

Cystic fibrosis-related mortality in the United States from 1999 to 2020: an observational analysis of time trends and disparities.

Singh H, Jani C, Marshall D, Franco R, Bhatt P, Podder S Sci Rep. 2023; 13(1):15030.

PMID: 37699961 PMC: 10497589. DOI: 10.1038/s41598-023-41868-x.

The first report on CFTR mutations of meconium ileus in cystic fibrosis population in Saudi Arabia: A single center review.

Banjar H, Qeretli R, Ramadan A, Al-Ibraheem A, Bnatig F Int J Pediatr Adolesc Med. 2022; 9(1):32-35.

PMID: 35573065 PMC: 9072234. DOI: 10.1016/j.ijpam.2021.03.008.

Probability of high-risk genetic matching with oocyte and semen donors: complete gene analysis or genotyping test?.

Molina Romero M, Yoldi Chaure A, Ganan Parra M, Navas Bastida P, Del Pico Sanchez J, Vaquero Arguelles A J Assist Reprod Genet. 2022; 39(2):341-355.

PMID: 35091964 PMC: 8956772. DOI: 10.1007/s10815-021-02381-0.

References

Wang J, Bowman M, Hsu E, Wertz K, Wong L . A novel mutation in the CFTR gene correlates with severe clinical phenotype in seven Hispanic patients. J Med Genet. 2000; 37(3):215-8. PMC: 1734535. DOI: 10.1136/jmg.37.3.215. View

Frischmeyer P, Dietz H . Nonsense-mediated mRNA decay in health and disease. Hum Mol Genet. 1999; 8(10):1893-900. DOI: 10.1093/hmg/8.10.1893. View

Bernardino A, Ferri A, Passos-Bueno M, Kim C, Nakaie C, Gomes C . Molecular analysis in Brazilian cystic fibrosis patients reveals five novel mutations. Genet Test. 2000; 4(1):69-74. DOI: 10.1089/109065700316516. View

Orozco L, Velazquez R, Zielenski J, Tsui L, Chavez M, Lezana J . Spectrum of CFTR mutations in Mexican cystic fibrosis patients: identification of five novel mutations (W1098C, 846delT, P750L, 4160insGGGG and 297-1G-->A). Hum Genet. 2000; 106(3):360-5. DOI: 10.1007/s004390051051. View

Wang J, Bowman C, Wong L . A novel CFTR frame-shift mutation, 935delA, in two Hispanic cystic fibrosis patients. Mol Genet Metab. 2000; 70(4):316-21. DOI: 10.1006/mgme.2000.3021. View

Wong L, Wang J, Woo M, Hsu E, Bowman C . A novel mutation detected by temporal temperature gradient gel electrophoresis led to the confirmative prenatal diagnosis of a Hispanic CF family. Prenat Diagn. 2000; 20(10):807-10. DOI: 10.1002/1097-0223(200010)20:10<807::aid-pd929>3.0.co;2-a. View

Grody W, Cutting G, Klinger K, Richards C, Watson M, Desnick R . Laboratory standards and guidelines for population-based cystic fibrosis carrier screening. Genet Med. 2001; 3(2):149-54. DOI: 10.1097/00125817-200103000-00010. View

Wong L, Wang J, Zhang Y, Hsu E, Heim R, Bowman C . Improved detection of CFTR mutations in Southern California Hispanic CF patients. Hum Mutat. 2001; 18(4):296-307. DOI: 10.1002/humu.1191. View

Acton J, Wilmott R . Phenotype of CF and the effects of possible modifier genes. Paediatr Respir Rev. 2002; 2(4):332-9. DOI: 10.1053/prrv.2001.0168. View

10.

Salvatore F, Scudiero O, Castaldo G . Genotype-phenotype correlation in cystic fibrosis: the role of modifier genes. Am J Med Genet. 2002; 111(1):88-95. DOI: 10.1002/ajmg.10461. View

11.

Richards C, Bradley L, Amos J, Allitto B, Grody W, Maddalena A . Standards and guidelines for CFTR mutation testing. Genet Med. 2002; 4(5):379-91. DOI: 10.1097/00125817-200209000-00010. View

12.

Wong L, Liang M, Kwon H, Park J, Bai R, Tan D . Comprehensive scanning of the entire mitochondrial genome for mutations. Clin Chem. 2002; 48(11):1901-12. View

13.

Mackie A, Thornton S, Edenborough F . Cystic fibrosis-related diabetes. Diabet Med. 2003; 20(6):425-36. DOI: 10.1046/j.1464-5491.2003.00924.x. View

14.

Keyeux G, Rodas C, Bienvenu T, Garavito P, Vidaud D, Sanchez D . CFTR mutations in patients from Colombia: implications for local and regional molecular diagnosis programs. Hum Mutat. 2003; 22(3):259. DOI: 10.1002/humu.9173. View

15.

Wilschanski M, Yahav Y, Yaacov Y, Blau H, Bentur L, Rivlin J . Gentamicin-induced correction of CFTR function in patients with cystic fibrosis and CFTR stop mutations. N Engl J Med. 2003; 349(15):1433-41. DOI: 10.1056/NEJMoa022170. View

16.

Watson M, Cutting G, Desnick R, Driscoll D, Klinger K, Mennuti M . Cystic fibrosis population carrier screening: 2004 revision of American College of Medical Genetics mutation panel. Genet Med. 2004; 6(5):387-91. PMC: 3110945. DOI: 10.1097/01.gim.0000139506.11694.7c. View

17.

Palomaki G, FitzSimmons S, Haddow J . Clinical sensitivity of prenatal screening for cystic fibrosis via CFTR carrier testing in a United States panethnic population. Genet Med. 2004; 6(5):405-14. DOI: 10.1097/01.gim.0000139505.06194.39. View

18.

Riordan J, Rommens J, Kerem B, Alon N, Rozmahel R, Grzelczak Z . Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science. 1989; 245(4922):1066-73. DOI: 10.1126/science.2475911. View

19.

Kerem B, Rommens J, Buchanan J, Markiewicz D, Cox T, Chakravarti A . Identification of the cystic fibrosis gene: genetic analysis. Science. 1989; 245(4922):1073-80. DOI: 10.1126/science.2570460. View

20.

Kerem B, Zielenski J, Markiewicz D, Bozon D, Gazit E, Yahav J . Identification of mutations in regions corresponding to the two putative nucleotide (ATP)-binding folds of the cystic fibrosis gene. Proc Natl Acad Sci U S A. 1990; 87(21):8447-51. PMC: 54973. DOI: 10.1073/pnas.87.21.8447. View